Showing 81 - 100 results of 102,699 for search '(((( ((i large) OR (a large)) decrease ) OR ( b large decrease ))) OR ( i also increased ))*', query time: 0.38s Refine Results
  1. 81
  2. 82
  3. 83

    Species-level changes in biomass due to large mammalian herbivore exclusion. by Arjun B. Potter (6445646)

    Published 2021
    “…Biomass data suggested larger increases in <i>Desmodium trifolium</i> (DESTRI) and larger declines in <i>Digitaria</i> sp. 1 (DIGITA) than percent cover data. …”
  4. 84
  5. 85
  6. 86

    Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

    Published 2021
    “…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91

    Supplementary Material for: Effects of White Matter Hyperintensities on 90-Day Functional Outcome after Large Vessel and Non-Large Vessel Stroke by Griessenauer C.J. (8965901)

    Published 2020
    “…<b><i>Material and Methods:</i></b> We reviewed acute ischemic stroke patients admitted between 2009 and 2017 at a large healthcare system in the USA. …”
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98

    Image_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”
  19. 99

    Table_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.xls by Zhixing Kuang (10809975)

    Published 2021
    “…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”
  20. 100